Efficacy and Safety of EsoDuo®

NCT06430047 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chong Kun Dang Pharmaceutical